Safety

Enhancing quality of life

Efficacy

Efficient tumor cell elimination

Delivery

Easy intravenous delivery
Service

Our mission is to deliver breakthrough cancer immunotherapies. Our passionate team is working towards improving and prolonging the lives of cancer patients. With a focus on research, translation, clinical development, manufacturing, and commercialization, we are committed to provide safe and effective tumor therapy.

About Us

We are an interdisciplinary team focused on providing breakthrough immunotherapies for cancer patients.

Read More

Our Approach

We are developing on a cutting-edge, fusion-based immuno-oncolytic therapy platform for intravenous delivery.

Read More

Investment

We are currently seeking investors to support final choic of our lead candidate and final process development steps.

Read More

Developments

Platform Technology

We are developing a whole platfrom appraoch consisting of a portfolio of immuno-oncolytic products targeting a variety of tumor indications, as well as a biomarker identification platform for patient selection and companion diagnostics.

Combination Therapies

FUSE vectors can reprogram the immune-suppressive tumor microenvironment to enable other immunotherapeutics to be more effective in combination approaches.

Portfolio

We are continuously working on the development of next generation viruses containing therapeutic transgenes that are optimized for immunotherapeutic efficiency and combination therapy.

Let's Chat!

Please contact us with any questions or comments. We would love to hear from you!